Xylonix.io is an innovative cancer immunotherapy development company for novel anticancer therapies that help realize the curative potential of cancer immunotherapy.
Today’s cancer immunotherapies demonstrated cure potentials across general cancer types, but the promblems of unpredictable treatment responses and low patient response rates remain. Our proprietary first-in-class Onco-Parthanatos platform technology kills and turns cancer into its own inflammatory antigens for initiating effective anti-cancer immune responses, for solving the reliability problems with today’s cancer immunotherapies.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 79 Anson Road, Singapore,singapore 079906,singapore
- Industry
- Biotechnology
- Website
- xylonix.io
- Keywords
- oncology, immunotherapy, diagnostics, cancer, pharmaceuticals, healthcare, science, tcells.
- HQ
- Singapore, Singapore
Xylonix.io Questions
Xylonix.Io's website is xylonix.io
Xylonix.Io's LinkedIn profile is https://sg.linkedin.com/company/xylonixio
Xylonix.Io has
4 employees.
View email and phone details for 4
employees at Xylonix.Io.
Xylonix.Io's industry is
Biotechnology
Xylonix.Io's top competitors are
Tech Brews,
Invitrocue,
Rpm Twist Co. Ltd.,
Healthy Talk,
Curigin Inc.,
Wellesta,
Genecast,
Key Risk Training Solutions,
Ek-Legein Connections,
Koh Creative.
Xylonix.Io's categories are Biotechnology
Xylonix.Io's founding year is 2016
